You have 9 free searches left this month | for more free features.

oral formulation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Participants Trial in Montreal (Semaglutide)

Recruiting
  • Healthy Participants
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Oct 18, 2023

Idiopathic Parkinson Disease Trial in Minneapolis (levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B,

Not yet recruiting
  • Idiopathic Parkinson Disease
  • levodopa/carbidopa oral formulation A
  • +2 more
  • Minneapolis, Minnesota
    University of Minnesota
Jul 20, 2022

Healthy Volunteers; High Cholesterol Trial in Los Angeles (NNC0385-0434 G, NNC0385-0434 F, NNC0385-0434 B)

Completed
  • Healthy Volunteers; High Cholesterol
  • NNC0385-0434 G
  • +2 more
  • Cypress, California
  • +1 more
Dec 19, 2022

Bioavailability Trial in Montréal (Filgotinib)

Not yet recruiting
  • Bioavailability
  • Montréal, Canada
    Altasciences
Sep 12, 2023

Malaria Trial (Piperaquine Phosphate)

Not yet recruiting
  • Malaria
  • Piperaquine Phosphate
  • (no location specified)
Jun 26, 2023

Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)

Completed
  • Hypertension
  • baxdrostat (formerly CIN-107) oral solution
  • Cincinnati, Ohio
    Medpace
Jul 18, 2023

Healthy Volunteers Trial in Tempe (Maribavir Commercial Tablet Formulation, Maribavir Pediatric Powder-for-oral Suspension

Not yet recruiting
  • Healthy Volunteers
  • Maribavir Commercial Tablet Formulation
  • +2 more
  • Tempe, Arizona
    Celerion
Jun 16, 2023

Healthy Trial in Springfield (Tasimelteon Oral Capsule, Tasimelteon Oral Suspension)

Active, not recruiting
  • Healthy
  • Tasimelteon Oral Capsule
  • Tasimelteon Oral Suspension
  • Springfield, Missouri
    Vanda Investigational Site
Oct 5, 2022

Safety, Bioavailability, Pharmacokinetics Trial in Ljubljana (Linaprazan glurate)

Completed
  • Safety
  • +2 more
  • Linaprazan glurate
  • Ljubljana, Ukmarjeva Ulica 6, Slovenia
    CRS d.o.o.
Jan 17, 2023

Upper Respiratory Tract Infection, Lower Respiratory Infection, Skin Infection Trial in Beijing (test product (T) azithromycin

Completed
  • Upper Respiratory Tract Infection
  • +4 more
  • test product (T) azithromycin capsule and reference product (R) azithromycin capsule "Sumamed®"
  • Beijing, Beijing, China
    Peking University People's Hospital
Nov 20, 2023

Pharmacokinetics Trial in Knoxville (MDMA)

Recruiting
  • Pharmacokinetics
  • Knoxville, Tennessee
    Alliance for Multispecialty Research LLC
Jul 27, 2022

Oral Health Trial (polyphenol-lecithin precipitate (PLP), control formulation)

Not yet recruiting
  • Oral Health
  • polyphenol-lecithin precipitate (PLP)
  • control formulation
  • (no location specified)
Mar 7, 2023

Healthy Trial (Drug: PF-07817883)

Not yet recruiting
  • Healthy
  • Drug: PF-07817883
  • (no location specified)
Nov 2, 2023

PreDiabetes, Glucose Tolerance Impaired Trial (APHD-012, APH-012P)

Not yet recruiting
  • PreDiabetes
  • Glucose Tolerance Impaired
  • (no location specified)
Apr 5, 2023

Healthy Trial in Nottingham (Ofev®, Nintedanib formulation 1, Nintedanib formulation 2)

Recruiting
  • Healthy
  • Nottingham, United Kingdom
    Quotient Sciences
Aug 9, 2022

Healthy Trial in Leeds (Vamifeport Formulation 1, Vamifeport Formulation 2)

Completed
  • Healthy
  • Vamifeport Formulation 1
  • Vamifeport Formulation 2
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit Ltd.
Aug 16, 2022

Osteoporosis, Postmenopausal, Type 2 Diabetes Trial in Seoul (Ibandronate Oral Tablet)

Completed
  • Osteoporosis, Postmenopausal
  • Type 2 Diabetes
  • Ibandronate Oral Tablet
  • Seoul, Korea, Republic of
    Yeouido St.Mary's Hospital
Mar 2, 2022

Tumor, Cancer Trial in Netherlands, United Kingdom, United States (AZD6244)

Active, not recruiting
  • Tumor
  • Cancer
  • Aurora, Colorado
  • +3 more
Dec 22, 2022

Healthy Trial in Biberach (BI 1810631 - trial formulation 1 (TF1), BI 1810631 - new formulation (NF), Rabeprazole sodium)

Completed
  • Healthy
  • BI 1810631 - trial formulation 1 (TF1)
  • +2 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Sep 16, 2022

Healthy Trial in Edegem (Macitentan)

Completed
  • Healthy
  • Edegem, Belgium
    SGS Belgium NV
Nov 8, 2022

Healthy Trial in Biberach (BI 1015550 ICF, BI 1015550 TF2)

Not yet recruiting
  • Healthy
  • BI 1015550 ICF
  • BI 1015550 TF2
  • (no location specified)
Aug 10, 2022

Healthy Trial in Biberach (BI 1815368 formulation 1, Placebo, BI 1815368 formulation 2)

Recruiting
  • Healthy
  • BI 1815368 formulation 1
  • +2 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Aug 10, 2022

Schizophrenia Trial in Tempe (10 mg CVL-231 as IR formulation, 30 mg CVL-231 as slow-release MR formulation, 30 mg CVL-231 as

Completed
  • Schizophrenia
  • 10 mg CVL-231 as IR formulation
  • +5 more
  • Tempe, Arizona
    Celerion Inc.
Apr 25, 2022

Premature Birth of Newborn Trial in Netanya (Oral Formulation of Insulin, Placebo)

Terminated
  • Premature Birth of Newborn
  • Oral Formulation of Insulin
  • Placebo
  • Netanya, Israel
    NICU, Laniado Hospital
Mar 16, 2021

Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)

Recruiting
  • Healthy Participants
  • Semaglutide J
  • Semaglutide C
  • Cypress, California
    Novo Nordisk Investigational Site
Mar 28, 2023